Back
Tango Therapeutics 10K Form
Buy
54
TNGX
Tango Therapeutics
Last Price:
3.10
Seasonality Move:
0.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TNGX News And Ratings
See the #1 stock for the next 7 days that we like better than TNGX
TNGX Financial Statistics
Sales & Book Value
Annual Sales: | $36.53M |
---|---|
Cash Flow: | $-33.51M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.13 |
Price / Book: | 1.55 |
Profitability
EPS (TTM): | -1.16000 |
---|---|
Net Income (TTM): | $-123.4M |
Gross Margin: | -- |
Return on Equity: | -48.54% |
Return on Assets: | -31.31% |
Tango Therapeutics Earnings Forecast
Key Tango Therapeutics Financial Ratios
- The Research & Development expenses have been 315.38% of Revenue.
- The Net Earning history of TNGX is -278.54% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 1 years.
Tango Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | TNGX |
Website: | tangotx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 8 |
Quick Ratio: | 7.8 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
TNGX Technical Analysis vs Fundamental Analysis
Buy
54
Tango Therapeutics (TNGX)
is a Buy
Is Tango Therapeutics a Buy or a Sell?
-
Tango Therapeutics stock is rated a Buy
The current Tango Therapeutics [TNGX] share price is $3.31. The Score for TNGX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.